1. Clinical & Scientific Overview
Calcium Carbonate (Typically Combined with Vitamin D3) (TIP-MED-000189, Reference Code [10.5]) is classified under
Vitamins, Minerals & Nutritional Supplements (Ch 10) as a Inorganic Calcium Salt (40% Elemental Calcium—Highest Elemental Yield; Requires Gastric Acid for Dissolution).
Within the Indian regulatory and compendial framework, it is governed under Non-Schedule / OTC or Schedule K Permitted Preparation (Medical Supervision Recommended for High-Dose/Therapeutic Regimens).
Representative Indian Market Examples (Edition 2.7 Ch 10 [10.5], p. 129): Shelcal 500 / Shelcal-HD (Torrent), Cipcal 500 (Cipla), Ostocalcium (GSK), Gemcal (Alkem—with Calcitriol), Calcimax — Strengths & Dosage Forms: Oral Film-Coated / Chewable Tablets: 1250 mg Calcium Carbonate = 500 mg Elemental Calcium (+ Vitamin D3 250 IU, 500 IU, or 1000 IU); Paediatric/Adult Suspension: 250 mg elemental Ca/5 mL
Oral Film-Coated / Chewable Tablets: 1250 mg Calcium Carbonate = 500 mg Elemental Calcium (+ Vitamin D3 250 IU, 500 IU, or 1000 IU); Paediatric/Adult Suspension: 250 mg elemental Ca/5 mL
3. Mechanism of Action & Pharmacodynamics
Inorganic Calcium Salt (40% Elemental Calcium—Highest Elemental Yield; Requires Gastric Acid for Dissolution) acting on target receptor/enzyme pathways in Vitamins, Minerals & Nutritional Supplements (Ch 10): clinical efficacy is mediated via Inorganic Calcium Salt (40% Elemental Calcium—Highest Elemental Yield; Requires Gastric Acid for Dissolution) for Prevention and treatment of calcium deficiency; adjunct to specific anti-osteoporotic therapy (bisphosphonates, denosumab, teriparatide) in postmenopausal and senile osteoporosis; glucocorticoid-induced osteoporosis prophylaxis (in patients on Prednisolone); pregnancy and lactation calcium supplementation; dietary phosphate binder in Chronic Kidney Disease (when taken WITH meals)..
4. Therapeutic Indications & Evidence-Supported Uses
- Prevention and treatment of calcium deficiency
- adjunct to specific anti-osteoporotic therapy (bisphosphonates, denosumab, teriparatide) in postmenopausal and senile osteoporosis
- glucocorticoid-induced osteoporosis prophylaxis (in patients on Prednisolone)
- pregnancy and lactation calcium supplementation
- dietary phosphate binder in Chronic Kidney Disease (when taken WITH meals)
🇮🇳 Jurisdiction & Indication Note: Indications and schedules reflect Indian compendial and regulatory records (CDSCO / Indian Pharmacopoeia & NFI / NLEM 2022). Where international reference labels (US FDA DailyMed / NCBI StatPearls) are cited for pharmacokinetic or mechanistic parameters, international approvals do not automatically imply CDSCO approval in India.
5. Educational Dosage Context, Formulations & Administration
Educational Dosing & Regimen Summary: General Adult Reference: 500 mg Elemental Calcium (1 tablet) once or twice daily (Total daily elemental calcium from diet + supplements should target 1000–1200 mg/day; never exceed 500–600 mg of elemental calcium in a single dose as intestinal saturable active transport [TRPV6] cannot absorb >500 mg at once!). Follow physician prescription.
Administration & Meal Timing: MUST be taken WITH or immediately AFTER a meal (typically Lunch)! (Calcium carbonate is water-insoluble and strictly requires gastric hydrochloric acid secreted during a meal to convert into soluble calcium chloride for absorption! Taking Calcium Carbonate on an empty stomach or while taking a PPI reduces absorption by >50%!). | After Lunch (01:30–02:30 PM)—scheduling Calcium after lunch automatically separates it by >6 hours from early-morning Levothyroxine, Bisphosphonates, and morning Iron/Antibiotics!
6. Pharmacokinetics, Metabolism & Renal/Hepatic Adjustment
Absorption, distribution, metabolism, and excretion follow class pharmacokinetic profile; verify patient renal/hepatic function.
Renal: In CKD Stages 3–5, Calcium Carbonate taken right with meals binds dietary phosphorus in the gut to treat hyperphosphataemia; however, total elemental calcium intake must be restricted (<1500 mg/day) and monitored closely to prevent adynamic bone disease and coronary/aortic vascular calcification! Hepatic: Safe.
Renal: In CKD Stages 3–5, Calcium Carbonate taken right with meals binds dietary phosphorus in the gut to treat hyperphosphataemia; however, total elemental calcium intake must be restricted (<1500 mg/day) and monitored closely to prevent adynamic bone disease and coronary/aortic vascular calcification! Hepatic: Safe.
Renal: In CKD Stages 3–5, Calcium Carbonate taken right with meals binds dietary phosphorus in the gut to treat hyperphosphataemia; however, total elemental calcium intake must be restricted (<1500 mg/day) and monitored closely to prevent adynamic bone disease and coronary/aortic vascular calcification! Hepatic: Safe.
7. Contraindications, Precautions & High-Risk Warnings
- Contraindicated in hypercalcaemia (primary hyperparathyroidism, malignancy, sarcoidosis, Vitamin D toxicity), severe hypercalciuria, and active calcium renal stones. Caution in achlorhydria / chronic high-dose PPI users (prefer Calcium Citrate!).
Key Clinical Precautions: Renal: In CKD Stages 3–5, Calcium Carbonate taken right with meals binds dietary phosphorus in the gut to treat hyperphosphataemia; however, total elemental calcium intake must be restricted (<1500 mg/day) and monitored closely to prevent adynamic bone disease and coronary/aortic vascular calcification! Hepatic: Safe.
8. Adverse Effects Profile
- Constipation, abdominal bloating, and flatulence/belching (gastric acid reacts with carbonate to release CO2 gas in the stomach), chalky taste.
- Hypercalcaemia, Milk-Alkali Syndrome (hypercalcaemia, metabolic alkalosis, and renal failure from excessive intake >3–4 g/day), nephrolithiasis (kidney stones—especially if taken on an empty stomach without food oxalate binding), vascular calcification in advanced CKD if calcium-phosphate product is elevated.
- Monitor for severe hypersensitivity, organ toxicity, or dose-limiting adverse events.
9. Major Drug–Drug, Drug–Food & Drug–Herb Interactions
- MAJOR CHELATION INTERACTIONS (Enforce 2-to-4 Hour Separation!): • Levothyroxine (Thyronorm): Calcium carbonate adsorbs T4 in the gut—space by AT LEAST 4 HOURS! • Oral Iron (Ferrous salts): Calcium inhibits DMT-1 mucosal iron uptake—do not take Iron and Calcium in the same meal! • Fluoroquinolones (Ciprofloxacin, Levofloxacin) & Tetracyclines (Doxycycline): Forms insoluble chelates—space antibiotic 2 hours before or 4–6 hours after Calcium! • Oral Bisphosphonates (Alendronate): Completely blocks bisphosphonate absorption—space by ≥2–4 hours! • Proton Pump Inhibitors (Pantoprazole/Omeprazole): Suppress gastric acid and impair Calcium Carbonate dissolution
- • Thiazide Diuretics: Increase risk of hypercalcaemia; Verapamil/CCBs: High calcium antagonises CCB effect; Digoxin: Hypercalcaemia precipitates digoxin arrhythmias
10. Clinical Monitoring, Patient Counselling & Storage
Clinical & Laboratory Monitoring: Monitor clinical response, baseline renal/hepatic parameters, and relevant serum biomarkers.
Pharmacist Patient Counselling Points:
- Patient Counselling Checklist: The 'Lunchtime Shelcal Rule': Instruct every patient: 'Always take your Calcium tablet right after Lunch—never in the early morning near your Thyroid or Acidity tablet, and never at the same meal as your Iron tablet!' Explain that taking it with lunch uses natural mealtime stomach acid to dissolve the tablet and binds dietary oxalates in the gut so kidney stones do not form.
- Meal & Clock Timing Instruction: MUST be taken WITH or immediately AFTER a meal (typically Lunch)! (Calcium carbonate is water-insoluble and strictly requires gastric hydrochloric acid secreted during a meal to convert into soluble calcium chloride for absorption! Taking Calcium Carbonate on an empty stomach or while taking a PPI reduces absorption by >50%!). (After Lunch (01:30–02:30 PM)—scheduling Calcium after lunch automatically separates it by >6 hours from early-morning Levothyroxine, Bisphosphonates, and morning Iron/Antibiotics!)
- Missed Dose Protocol: Take with the next meal (e.g., dinner, provided no interacting iron or antibiotic is taken at dinner); never take two 500 mg calcium tablets at the same time.
- Geriatric Dispensing Pearl: In elderly CGHS patients who take daily Pantoprazole/Omeprazole (achlorhydria), suffer from chronic constipation, or have a history of kidney stones, Calcium Citrate Malate (CCM) is clinically superior to Calcium Carbonate.
Storage, Stability & Dispensing Safeguards: Store below 25°C–30°C in original moisture- and light-resistant packaging out of reach of children. Available forms: Oral Film-Coated / Chewable Tablets: 1250 mg Calcium Carbonate = 500 mg Elemental Calcium (+ Vitamin D3 250 IU, 500 IU, or 1000 IU); Paediatric/Adult Suspension: 250 mg elemental Ca/5 mL
11. Visual Pharmacology & Mechanism Diagram (svg-v339-01-adme-12-step-journey)
12. Authoritative References, Regulatory Sources & Editorial Disclaimer
Primary Compendial & Guideline Reference: Indian Pharmacist Desk Reference — Professional Edition 2.7 (2026–27) • Ch 10 [10.5] (p. 129)
Official Verification Portals: Indian Pharmacopoeia Commission (IPC) & National Formulary of India (NFI) • Central Drugs Standard Control Organization (CDSCO) • Ministry of Health & Family Welfare — NLEM 2022 • NCBI Bookshelf / StatPearls Pharmacology Reference • DailyMed (US FDA Official Prescribing Reference)
Last Medically & Pharmaceutically Reviewed: 2026-11-10 • Verification Status: HANDBOOK_SOURCE_CONTENT
Educational & Clinical Disclaimer: This reference profile is published solely for pharmacy education, academic study, and professional clinical reference. It does not substitute for patient-specific clinical judgement, qualified specialist oncology/medical supervision, or official CDSCO/IP prescribing information. Never self-medicate with prescription, Schedule H/H1/X, NDPS, or oncology medicines.
13. Related Reference Monographs, Educational Guides & Visual Concept
💊 Related Pharmacological / Category Profiles
- [10.16]-CMP123 Oral Isotretinoin (13-cis-Retinoic Acid) IP — Fat-Soluble Retinoid Epithelial/Visual Vitamin & Lipid-Peroxidati
- [10.17]-C124 Coenzyme Q10 (Ubidecarenone) — Mitochondrial Metabolic Coenzymes & Neuropathic/Myopathic Antioxi
- [10.17]-C125 L-Carnitine — Mitochondrial Metabolic Coenzymes & Neuropathic/Myopathic Antioxi
- [10.1] Vitamin B12 (Methylcobalamin / Mecobalamin & Cyanocobalamin) — Water-Soluble Neurotropic & Haematinic Vitamin (Cobalamin; Coenzy